Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tofacitinib Prodrug-1 is an effective and oral active prodrug to mitigate the systemic adverse effects of Tofacitinib. Tofacitinib Prodrug-1 can effectively attenuate the oxazolone-induced colitis in mice model with low toxicity. Tofacitinib Prodrug-1 is a potential drug candidate for the treatment of ulcerative colitis .
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $3,920 | 10-14 weeks | |
50 mg | $5,180 | 10-14 weeks | |
100 mg | $7,300 | 10-14 weeks |
Description | Tofacitinib Prodrug-1 is an effective and oral active prodrug to mitigate the systemic adverse effects of Tofacitinib. Tofacitinib Prodrug-1 can effectively attenuate the oxazolone-induced colitis in mice model with low toxicity. Tofacitinib Prodrug-1 is a potential drug candidate for the treatment of ulcerative colitis . |
Molecular Weight | 759.21 |
Formula | C36H39ClN10O7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.